Lepu Medical Technology (300003) Stock Overview

Lepu Medical Technology (Beijing) Co., Ltd. engages in the development, manufacture, and distribution of medical devices and equipment in China, India, the Netherlands, and the United States. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters and Angiocide peripheral cutting balloon; cardiovascular products, such as coronary stents and balloons, catheter, guide wires, introducer sheaths, fractional flow reserve, and accessories; and neurointerventional products. It also provides digital subtraction angiography system; congenital heart disease products; cardiac rhythm management products that comprise electrophysiology, pacemaker and lead, and equipment; ECG, patient monitor, and oximeter; home medical equipment; critical care products; dialyzer, hemoperfutor, and hemodialysis accessories; in vitro diagnostics comprising hematology, point of care testing, immunoassay, molecular diagnostic, and biochemistry; surgical products, which include ultrasonic surgical system, surgical stapler, endoscopic ultrasound system; portable, trolley, and veterinary ultrasound products; oncology diagnostics; and orthopedic products. In addition, the company offers APIs and FDFs for cardiovascular, anti-infectives, oncology, central nervous system, and other diseases; and offers skin care products under the LEPU LAB brand name; and polymerase chain reaction solutions, SARS-CoV-2 test kits, infrared forehead thermometers, patient monitors, pulse oximeters, sterile syringes, and neutralization antibody test kits. Lepu Medical Technology (Beijing) Co., Ltd. was founded in 1999 and is headquartered in Beijing, China.